Protective Autophagy or Autophagic Death: Effects of BEZ235 on Chronic Myelogenous Leukemia

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s204472
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Chronic Myelogenous Leukemia

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Immunological Studies on Chronic Myelogenous Leukemia

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1976English

Chronic Myelogenous Leukemia Molecular Signature

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Erythroid Variant of Chronic Myelogenous Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Evolution of Therapies for Chronic Myelogenous Leukemia

Cancer Journal
Cancer ResearchOncology
2011English

Efficacy of the Dual PI3K and mTOR Inhibitor NVP-BEZ235 in Combination With Imatinib Mesylate Against Chronic Myelogenous Leukemia Cell Lines

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Thrombotic Thrombocytopenic Purpura in Chronic Myelogenous Leukemia

Canadian Journal of Ophthalmology
MedicineOphthalmology
2020English

The Apoptosis/Autophagy Paradox: Autophagic Vacuolization Before Apoptotic Death

Journal of Cell Science
Cell Biology
2005English

Bosutinib in the Management of Chronic Myelogenous Leukemia

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy